{"id":204820,"name":"FOUNDATION MEDICINE","slug":"foundation-medicine","state":"MA","country":"United States of America","description":"Molecular insight company, connects physicians & patients to the latest cancer treatment","totalSpending":1950000,"filings":26,"yearlySpending":[{"year":2020,"income":190000},{"year":2021,"income":400000},{"year":2022,"income":400000},{"year":2023,"income":320000},{"year":2024,"income":320000},{"year":2025,"income":320000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["RAISSA DOWNS","JENNIFER YOUNG","MICHELLE EASTON","ELIZABETH MURRAY","CHARLOTTE IVANCIC","PAMELA SMITH","EMILY MURRY","KIMBERLY BRANDT","MARGARET JOSEPH","PETER FISE","LAURA FRIEDEL","PARICK CARROLL"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","Homeland Security, Dept of (DHS)"],"sampleDescriptions":["Companion diagnostics, genomics testing, cancer therapies, FDA user fee reauthorization","Companion diagnostics, genomics testing, cancer therapies, FDA user fee reauthorization","Companion diagnostics, genomics testing, cancer therapies, FDA user fee reauthorization","companion diagnostics\nH.R. 6800 - The Heroes Act","companion diagnostics"]}